Double-blind randomized trial of aflibercept versus placebo with docetaxel and prednisone for treatment of metastatic castration-resistant prostate cancer (mCRPC)
dc.contributor.author | Skoneczna, Iwona Anna | |
dc.contributor.author | Tannock, Ian | |
dc.contributor.author | Fizazi, Karim | |
dc.contributor.author | Ivanov, Sergey | |
dc.contributor.author | Thellenberg-Karlsson, Camilla | |
dc.contributor.author | Flechon, Aude | |
dc.contributor.author | Orlandi, Francisco Jorquera | |
dc.contributor.author | Gravis, Gwenaelle | |
dc.contributor.author | Matveev, Vsevolod | |
dc.contributor.author | Bavbek, Sevil E. | |
dc.contributor.author | Gil, Thierry | |
dc.contributor.author | Viana, Luciano S. | |
dc.contributor.author | Aren, Osvaldo | |
dc.contributor.author | Karyakin, Oleg | |
dc.contributor.author | Elliott, Tony | |
dc.contributor.author | Birtle, Alison J. | |
dc.contributor.author | Magherini, Emmanuelle | |
dc.contributor.author | Petrylak, Daniel Peter | |
dc.contributor.author | Tombal, Bertrand | |
dc.contributor.author | Rosenthal, Mark | |
dc.date.accessioned | 2021-03-02T22:47:43Z | |
dc.date.available | 2021-03-02T22:47:43Z | |
dc.identifier.citation | Tannock I., Fizazi K., Ivanov S., Thellenberg-Karlsson C., Flechon A., Skoneczna I. A. , Orlandi F. J. , Gravis G., Matveev V., Bavbek S. E. , et al., "Double-blind randomized trial of aflibercept versus placebo with docetaxel and prednisone for treatment of metastatic castration-resistant prostate cancer (mCRPC)", 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_0ec6bdd6-feb8-4966-9c34-c2b5682d50be | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/15468 | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Onkoloji | |
dc.title | Double-blind randomized trial of aflibercept versus placebo with docetaxel and prednisone for treatment of metastatic castration-resistant prostate cancer (mCRPC) | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 31 | |
dc.contributor.firstauthorID | 141678 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Bildiri [64839]